Coherus Oncology (CHRS) Shares Outstanding (Diluted) (2015 - 2026)
Coherus Oncology (CHRS) reported Shares Outstanding (Diluted) of 154.82 million for Q2 2026, up 33.4% from 116.08 million a year earlier and up 13.5% from the prior quarter.
Coherus Oncology (CHRS) Shares Outstanding (Diluted) (2015 - 2026) Analysis & Trends
For FY2025, Coherus Oncology posted Shares Outstanding (Diluted) of 117.14 million, up 2.0% from FY2024.
- Shares Outstanding (Diluted) has increased for four consecutive years, with a five-year compound annual growth rate of 7.0% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 114.83 million in FY2024 (+21.9%), 94.16 million in FY2023 (+21.3%), 77.63 million in FY2022 (+2.9%) and 75.45 million in FY2021 (-9.6%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q3 2015.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last five quarters, with growth averaging 10.9% over the last eight quarters.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q1 2024 (growth of 58.4%); the low point was Q3 2021 (a decline of 9.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 136.4 million (Q1 2026), 117.14 million (Q4 2025) and 116.23 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 154.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154.82 Mn |
| Mar 31, 2026 | 136.40 Mn |
| Dec 31, 2025 | 117.14 Mn |
| Sep 30, 2025 | 116.23 Mn |
| Jun 30, 2025 | 116.08 Mn |
| Mar 31, 2025 | 115.86 Mn |
| Dec 31, 2024 | 114.83 Mn |
| Sep 30, 2024 | 115.21 Mn |
| Jun 30, 2024 | 114.82 Mn |
| Mar 31, 2024 | 125.53 Mn |
| Dec 31, 2023 | 94.16 Mn |
| Sep 30, 2023 | 97.74 Mn |
| Jun 30, 2023 | 87.27 Mn |
| Mar 31, 2023 | 79.27 Mn |
| Dec 31, 2022 | 77.63 Mn |
| Sep 30, 2022 | 77.75 Mn |
| Jun 30, 2022 | 77.55 Mn |
| Mar 31, 2022 | 77.25 Mn |
| Dec 31, 2021 | 75.45 Mn |
| Sep 30, 2021 | 79.01 Mn |
Coherus Oncology Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CHRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();